MUMBAI, India, June 30 -- Intellectual Property India has published a patent application (202647074593 A) filed by Shanghai Hansoh Biomedical Co. , Ltd.; and Jiangsu Hansoh Pharmaceutical Group Co. , Ltd. on June 16, 2026, for Heterocyclic Carbonyl Derivative Modulator, Preparation Method Therefor, And Use Thereof.
Inventors include Xiao, Hualing; Cheng, Bao; Liu, Yong; Fan, Bobo; and Su, Yidong.
The application for the patent was published on June 26, 2026, under issue no. 26/2026.
Abstract: The present invention relates to a heterocyclic carbonyl derivative modulator, a preparation method therefor, and the use thereof. Specifically, the present invention relates to a compound represented by general formula (II-B), a preparation method therefor, a pharmaceutical composition containing said compound, and a use thereof as a modulator in the treatment of Alzheimer’s disease, schizophrenia, pain, addiction, and sleep disorders, wherein each substituent in general formula (II-B) is as defined in the description.
Disclaimer: Curated by HT Syndication.
